Sessions

WHERE ARE WE NOW? MECHANISATION IN CELL & GENE THERAPY
DIGITALISATION & DATA MANAGEMENT IN CELL & GENE THERAPY
FUTURE OF AUTOMATION FOR ADVANCED THERAPIES

WHERE ARE WE NOW? MECHANISATION IN CELL & GENE THERAPY

01 Sep 2022
11:00
SPONSORED BY
Miltenyi Biotec

11:00 – CHAIR INTRODUCTION

Chair: John Campbell, Director, Tissues, Cells and Advanced Therapeutics, Scottish National Blood Transfusion Service

 

11:05 – PRESENTATION

Speaker: John Campbell, Director, Tissues, Cells and Advanced Therapeutics, Scottish National Blood Transfusion Service

 

11:20 – PRESENTATION: AUTOMATION OF CGTs – FOLLOWING THE ONION PRINCIPLE

Speakers: Silvio Weber, Scientific Director, Industrial Workflow Development, Cellular Therapy, Miltenyi Biotec

 

11:35 – PRESENTATION: Manufacturing automation for early phase ATMP clinical trials

Speaker: Stuart Curbishley, Head of Business and Project Development – Advanced Therapies, University of Birmingham

 

11.50 – PRESENTATION: 

Speaker: Senior Representative, Aglaris

 

12:05 – SPEAKER Q&A

Speakers: 

Stuart Curbishley, Head of Business and Project Development – Advanced Therapies, University of Birmingham

Silvio Weber, Scientific Director, Industrial Workflow Development, Cellular Therapy, Miltenyi Biotec

Senior Representative, Aglaris

Speakers

John Campbell
Director, Tissues Cells & Advanced Therapeutics
Scottish National Blood Transfusion Service
Silvio Weber
Director Industrial Workflow Development, Cellular Therapy
Miltenyi Biotec
Stuart Curbishley
Head of Business and Project Development - Advanced Therapies
University of Birmingham